{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:10:38Z","timestamp":1791486638788,"version":"4.3.4"},"reference-count":102,"publisher":"ScopeMed","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.matersociomed.org\/\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.5455\/msm.2019.31.190-196","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T16:16:12Z","timestamp":1569255372000},"source":"Crossref","is-referenced-by-count":6,"title":["Vaccination Coverage and Awareness of Hepatitis B Virus Among Healthcare Students at a University in Cyprus"],"prefix":"10.5455","member":"3407","reference":[{"key":"ref1","unstructured":"1. Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hepatology. 2009; 49(5 Suppl): S56-S60.","DOI":"10.1002\/hep.22962"},{"key":"ref3","unstructured":"2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboy -"},{"key":"ref4","unstructured":"ans V, et al. Global and regional mortality from 235 causes"},{"key":"ref5","unstructured":"of death for 20 age groups in 1990 and 2010: a systematic"},{"key":"ref6","unstructured":"analysis for the global burden of disease study 2010. Lancet."},{"key":"ref7","unstructured":"2012; 380(9859): 2095-2128."},{"key":"ref8","unstructured":"3. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemi -"},{"key":"ref9","unstructured":"ology of hepatitis B virus infection: new estimates of age-"},{"key":"ref10","unstructured":"specific HBsAg seroprevalence and endemicity. Vaccine. 2012;"},{"key":"ref11","unstructured":"30(12): 2212-2219."},{"key":"ref12","unstructured":"4. Papastergiou V, Lombardi R, MacDonald D, Tsochatzis EA."},{"key":"ref13","unstructured":"Global epidemiology of hepatitis B virus (HBV) infection."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Curr Hepat Rep. 2015; 14(3): 171-178.","DOI":"10.1007\/s11901-015-0269-3"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"5. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009.","DOI":"10.1002\/hep.23190"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Hepatology. 2009; 50(3): 661-662.","DOI":"10.1002\/hep.23190"},{"key":"ref17","unstructured":"6. Zheng Y, Lu Y, Ye Q, Xia Y, Zhou Y, Yao Q, et al. Should chronic"},{"key":"ref18","unstructured":"hepatitis B mothers breastfeed? a meta analysis. BMC Public"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Health. 2011; 11: 502.","DOI":"10.1484\/J.QUAESTIO.1.103034"},{"key":"ref20","unstructured":"7. Lavanchy D. Viral hepatitis: global goals for vaccination. J"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Clin Virol. 2012; 55(4): 296-302.","DOI":"10.1016\/j.jcv.2012.08.022"},{"key":"ref22","unstructured":"8. FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepa -"},{"key":"ref23","unstructured":"titis B vaccination: a completed schedule enough to control"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"HBV lifelong? . Vaccine. 2013; 31(4): 584-590.","DOI":"10.1016\/j.vaccine.2012.10.101"},{"key":"ref25","unstructured":"9. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli"},{"key":"ref26","unstructured":"L, et al. A comprehensive immunization strategy to elimi -"},{"key":"ref27","unstructured":"nate transmission of hepatitis B virus infection in the United"},{"key":"ref28","unstructured":"States: recommendations of the Advisory Committee on Im -"},{"key":"ref29","unstructured":"munization Practices (ACIP) Part II: immunization of adults."},{"key":"ref30","unstructured":"MMWR Recomm Rep. 2006; 55(Rr-16): 1-33."},{"key":"ref31","unstructured":"10. Puro V, De Carli G, Cicalini S, Soldani F, Balslev U, Begovac"},{"key":"ref32","unstructured":"J, et al. European recommendations for the management of"},{"key":"ref33","unstructured":"healthcare workers occupationally exposed to hepatitis B"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"virus and hepatitis C virus. Euro Surveill. 2005; 10(10): 260-","DOI":"10.1007\/0-387-35103-5_2"},{"key":"ref35","unstructured":"11. Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea"},{"key":"ref36","unstructured":"L, et al. Antibody levels and protection after Hepatitis B Vac -"},{"key":"ref37","unstructured":"cine: Results of a 30-year follow-up study and response to a"},{"key":"ref38","unstructured":"booster dose. J Infect Dis. 2016; 214(1): 16-22.12. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, F\u00e9rey M-P,"},{"key":"ref39","unstructured":"Ebel A, et al. Sensitivities of four new commercial hepatitis"},{"key":"ref40","unstructured":"B virus surface antigen (HBsAg) assays in detection of HBsAg"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"mutant forms. J Clin Microbiol. 2006; 44(7): 2321-2326.","DOI":"10.1128\/JCM.00121-06"},{"key":"ref42","unstructured":"13. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H,"},{"key":"ref43","unstructured":"Hurlburt D, et al. Antibody levels and protection after hepati -"},{"key":"ref44","unstructured":"tis b vaccine: results of a 22-year follow-up study and response"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"to a booster dose. J Infect Dis. 2009; 200(9): 1390-1396.","DOI":"10.1086\/606119"},{"key":"ref46","unstructured":"14. Zhang J-M, Xu Y, Wang X-Y, Yin Y-K, Wu X-H, Weng X-H, et"},{"key":"ref47","unstructured":"al. Coexistence of hepatitis B surface antigen (HBsAg) and"},{"key":"ref48","unstructured":"heterologous subtype-specific antibodies to HBsAg among"},{"key":"ref49","unstructured":"patients with chronic hepatitis B virus infection. Clin Infect"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Dis. 2007; 44(9): 1161-1169.","DOI":"10.1080\/10601320701561072"},{"key":"ref51","unstructured":"15. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P. Fre -"},{"key":"ref52","unstructured":"quency and significance of concurrent hepatitis B surface"},{"key":"ref53","unstructured":"antigen and antibody in acute and chronic hepatitis B. Gas-"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"troenterology. 1987; 93(4): 675-680.","DOI":"10.1016\/0016-5085(87)90427-6"},{"key":"ref55","unstructured":"16. Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y. Mutations"},{"key":"ref56","unstructured":"in the envelope gene of hepatitis B virus variants co-occur -"},{"key":"ref57","unstructured":"ring with antibody to surface antigen in sera from patients"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"with chronic hepatitis B. J Gen Virol. 1996; 77: 1825-1831.","DOI":"10.1099\/0022-1317-77-8-1825"},{"key":"ref59","unstructured":"17. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of"},{"key":"ref60","unstructured":"hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies"},{"key":"ref61","unstructured":"in chronic hepatitis B virus carriers: influence of \u201ca\u201d deter -"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"minant variants. J Virol. 2006; 80(6): 2968-2975.","DOI":"10.1128\/JVI.80.6.2968-2975.2006"},{"key":"ref63","unstructured":"18. Mesenas SJ, Chow WC, Zhao Y, Lim GK, Oon CJ, Ng HS. Wild-"},{"key":"ref64","unstructured":"type and \u2018a\u2019 epitope variants in chronic hepatitis B virus car -"},{"key":"ref65","unstructured":"riers positive for hepatitis B surface antigen and antibody. J"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Gastroenterol Hepatol. 2002; 17(2): 148-152.","DOI":"10.1046\/j.1440-1746.2002.02627.x"},{"key":"ref67","unstructured":"19. Mathet VL, Feld M, Espinola L, Sanchez DO, Ruiz V, Mando"},{"key":"ref68","unstructured":"O, et al. Hepatitis B virus S gene mutants in a patient with"},{"key":"ref69","unstructured":"chronic active hepatitis with circulating anti-HBs antibodies."},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"J Med Virol. 2003; 69(1): 18-26.","DOI":"10.1046\/j.1525-1497.18.s1.15.x"},{"key":"ref71","unstructured":"20. Palmovi\u0107 D. Prevention of hepatitis B infection in health"},{"key":"ref72","unstructured":"care workers after accidental exposure. J Infect. 1987; 15(3):"},{"key":"ref73","unstructured":"21. Erhabor O, Ejele OA, Nwauche CA. Epidemiology and man -"},{"key":"ref74","unstructured":"agement of occupational exposure to blood borne viral in -"},{"key":"ref75","unstructured":"fections in a resource poor setting: the case for availability"},{"key":"ref76","unstructured":"of post exposure prophylaxis. Niger J Clin Pract. 2007; 10(2):"},{"key":"ref77","unstructured":"22. Saridi M, Toska A, Souliotis K, N O, M S, Stamatiou K, et al."},{"key":"ref78","unstructured":"Vaccination coverage among health care workers in a Greek"},{"key":"ref79","unstructured":"hospital. J Vaccines Vaccin. 2011; 2: 1-8."},{"key":"ref80","unstructured":"23. Cavalieri SJ, Hrabovsky S, Jorgensen T. Comparison of Dia -"},{"key":"ref81","unstructured":"Sorin and Bio-Rad test kits for the detection of Hepatitis B"},{"key":"ref82","unstructured":"Virus total core and surface antibodies on the Bio-Rad evolis."},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Am J Clin Pathol. 2010; 133(1): 110-113.","DOI":"10.1309\/AJCPHY8P2LOIKFBE"},{"key":"ref84","unstructured":"24. Hourfar MK, Walch LA, Geusendam G, Dengler T, Janetzko K,"},{"key":"ref85","unstructured":"Gubbe K, et al. Sensitivity and specificity of Anti-HBc screen -"},{"key":"ref86","unstructured":"ing assays--which assay is best for blood donor screening?"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Int J Lab Hematol. 2009; 31(6): 649-656.","DOI":"10.1111\/j.1751-553X.2008.01092.x"},{"key":"ref88","unstructured":"25. Wang Q, Klenerman P, Semmo N. Significance of anti-HBc"},{"key":"ref89","unstructured":"alone serological status in clinical practice. Lancet Gastro -"},{"key":"ref90","unstructured":"enterol Hepatol. 2017; 2(2): 123-134."},{"key":"ref91","unstructured":"26. Krajden M, McNabb G, Petric M. The laboratory diagnosis of"},{"key":"ref92","unstructured":"hepatitis B virus. Can J  Infect Dis Med Microbiol. 2005; 16(2):"},{"key":"ref93","unstructured":"27. Yasobant S, Trivedi P, Saxena D, Puwar T, Vora K, Patel M."},{"key":"ref94","unstructured":"Knowledge of hepatitis B among healthy population: A com -"},{"key":"ref95","unstructured":"munity-based survey from two districts of Gujarat, India. J"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Family Med Prim Care. 2017; 6(3): 589-594.","DOI":"10.4103\/2249-4863.222009"},{"key":"ref97","unstructured":"28. Jha S, Devaliya D, Bergson S, Desai S. Hepatitis B knowledge"},{"key":"ref98","unstructured":"among women of childbearing age in three slums in Mumbai:"},{"key":"ref99","unstructured":"a cross-sectional survey. Hepatol Med Policy. 2016; 1: 5."},{"key":"ref100","unstructured":"29. Loftin C, Campanella H, Gilbert S. Ethical issues in nursing"},{"key":"ref101","unstructured":"education: the dual-role researcher. Teach Learn Nurs. 2011;"},{"key":"ref102","unstructured":"6(3): 139-143."}],"container-title":["Materia Socio Medica"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/16\/16-1569263888.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:07:39Z","timestamp":1791482859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/16\/16-1569263888.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":102,"URL":"https:\/\/doi.org\/10.5455\/msm.2019.31.190-196","relation":{},"ISSN":["1512-7680"],"issn-type":[{"value":"1512-7680","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}